Profile of musculoskeletal pain in patients with inflammatory bowel disease: a study protocol for assessing the multidimensional experience of self-reported pain

References

• Bliddal H, Danneskiold-Samsøe B. Chronic widespread pain in the spectrum of rheumatological diseases. Best Pract Res Clin Rheumatol. 2007;21(3):391–402.
   PubMed Web of Science ®Google Scholar
• Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015;50(8):942–951.
   PubMed Web of Science ®Google Scholar
• M'Koma AE. Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol. 2013;6:33.
   PubMedGoogle Scholar
• Sheth T, Pitchumoni CS, Das KM. Management of musculoskeletal manifestations in inflammatory bowel disease. Gastroenterol Res Pract. 2015;2015 (no pagination)(387891).
   PubMedGoogle Scholar
• Molodecky NA, Soon S, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.e42.
   PubMed Web of Science ®Google Scholar
• Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727.
   PubMed Web of Science ®Google Scholar
• Zeitz J, Ak M, Müller-Mottet S, Scharl S, Biedermann L, Fournier N, et al. Pain in IBD patients: very frequent and frequently insufficiently taken into account. PLoS One. 2016;11(6):e0156666.
   PubMed Web of Science ®Google Scholar
• Van Erp S, Brakenhoff L, van Gaalen F, van den Berg R, Fidder H, Verspaget H, et al. Classifying back pain and peripheral joint complaints in inflammatory bowel disease patients: a prospective longitudinal follow up study. J Crohn's Colitis. 2015;10(2):166–175.
   Google Scholar
• Palm Ø, Bernklev T, Moum B, Gran JT. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J Rheumatol. 2005;32(9):1755–1759.
   PubMed Web of Science ®Google Scholar
• van der Have M, Brakenhoff LK, van Erp SJ, Kaptein AA, Leenders M, Scharloo M, et al. Back/joint pain, illness perceptions and coping are important predictors of quality of life and work productivity in patients with inflammatory bowel disease: a 12-month longitudinal study. J Crohn's Colitis. 2015;9(3):276–283.
   Google Scholar
• Brakenhoff LK, van der Heijde DM, Hommes DW. IBD and arthropathies: a practical approach to its diagnosis and management. Gut. 2011;60(10):1426–1435.
   PubMed Web of Science ®Google Scholar
• Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohn's Colitis. 2016;10(3):239–254.
   Google Scholar
• Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (NY). 2011;7(4):235–241.
   PubMedGoogle Scholar
• Trikudanathan G, Venkatesh PG, Navaneethan U. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs. 2012;72(18):2333–2349.
   PubMed Web of Science ®Google Scholar
• Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(8):1982–1992.
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Calabrese C, Rizzello F. Inflammatory bowel diseases and spondyloarthropathies. J Rheumatol Suppl. 2015;93:21–23.
   PubMedGoogle Scholar
• Conigliaro P, Chimenti MS, Ascolani M, Triggianese P, Novelli L, Onali S, et al. Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients. Autoimmun Rev. 2016;15(2):184–190.
   PubMed Web of Science ®Google Scholar
• Bourikas LA, Papadakis KA. Musculoskeletal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(12):1915–1924.
   PubMedGoogle Scholar
• Bielefeldt K, Davis B, Binion DG. Pain and inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(5):778–788.
   PubMed Web of Science ®Google Scholar
• Lee YC, Frits ML, Iannaccone CK, Weinblatt ME, Shadick NA, Williams DA, et al. Subgrouping of patients with rheumatoid arthritis based on pain, fatigue, inflammation, and psychosocial factors. Arthritis Rheumatol. 2014;66(8):2006–2014.
   PubMed Web of Science ®Google Scholar
• Loevinger BL, Shirtcliff EA, Muller D, Alonso C, Coe CL. Delineating psychological and biomedical profiles in a heterogeneous fibromyalgia population using cluster analysis. Clin Rheumatol. 2012;31(4):677–685.
   PubMed Web of Science ®Google Scholar
• Rehm SE, Koroschetz J, Gockel U, Brosz M, Freynhagen R, Tolle TR, et al. A cross-sectional survey of 3035 patients with fibromyalgia: subgroups of patients with typical comorbidities and sensory symptom profiles. Rheumatology (UK). 2010;49(6):1146–1152.
   PubMed Web of Science ®Google Scholar
• de Luca K, Parkinson L, Downie A, Blyth F, Byles J. Three subgroups of pain profiles identified in 227 women with arthritis: a latent class analysis. Clin Rheumatol. 2016;36(3):625–634.
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1-2):9–19.
   PubMed Web of Science ®Google Scholar
• Verra ML, Angst F, Brioschi R, Lehmann S, Keefe FJ, Staal JB, et al. Does classification of persons with fibromyalgia into Multidimensional Pain Inventory subgroups detect differences in outcome after a standard chronic pain management program? Pain Res Manag. 2009;14(6):445–453.
   PubMed Web of Science ®Google Scholar
• Davis SNP, Binik YM, Amsel R, Carrier S. A subtype based analysis of urological chronic pelvic pain syndrome in men. J Urol. 2013;190(1):118–123.
   PubMed Web of Science ®Google Scholar
• Draper T, Ormseth SR, Custodio M, Weisman MH, Irwin MR, Nicassio PM. Identifying subgroups of rheumatoid arthritis patients based on levels of pain, disability, and depression. Arthritis Rheum. 2012;64:S673.
   Google Scholar
• Jensen MP. Review of measures of neuropathic pain. Curr Pain Headache Rep. 2006;10(3):159–166.
   PubMedGoogle Scholar
• Edwards RR, Dworkin RH, Turk DC, Angst MS, Dionne R, Freeman R, et al. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain. 2016;157(9):1851–1871.
   PubMed Web of Science ®Google Scholar
• Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3):S2–S15.
   PubMed Web of Science ®Google Scholar
• Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003;106(3):337–345.
   PubMed Web of Science ®Google Scholar
• Hoddinott SN, Bass MJ. The dillman total design survey method. Can Fam Physician. 1986;32:2366.
   PubMed Web of Science ®Google Scholar
• Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self‐administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Care Res (Hoboken). 2003;49(2):2363–2366.
   Web of Science ®Google Scholar
• Neblett R, Cohen H, Choi Y, Hartzell MM, Williams M, Mayer TG, et al. The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain. 2013;14(5):438–445.
   PubMed Web of Science ®Google Scholar
• Mayer TG, Neblett R, Cohen H, Howard KJ, Choi YH, Williams MJ, et al. The development and psychometric validation of the Central Sensitization Inventory. Pain Pract. 2012;12(4):276–285.
   PubMed Web of Science ®Google Scholar
• Evertsz FB, Hoeks CC, Nieuwkerk PT, Stokkers PC, Ponsioen CY, Bockting CL, et al. Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn’s disease activity. J Clin Gastroenterol. 2013;47(10):850–856.
   PubMed Web of Science ®Google Scholar
• Walsh AJ, Bryant RV, Travis SP. Current best practice for disease activity assessment in IBD. Nat Rev Gastroenterol Hepatol. 2016;13(10):567–579.
   PubMed Web of Science ®Google Scholar
• Higgins PD, Leung J, Schwartz M, Mapili J, Wren P, Zimmermann E. The quantitative validation of non‐endoscopic disease activity indices in ulcerative colitis. Aliment Pharmacol Ther. 2007;25(3):333–342.
   PubMed Web of Science ®Google Scholar
• Evertsz FB, Nieuwkerk PT, Stokkers PC, Ponsioen CY, Bockting CL, Sanderman R, et al. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers. J Crohn's Colitis. 2013;7(11):890–900.
   Google Scholar
• Peyrin-Biroulet L, Panés J, Sandborn WJ, Vermeire S, Danese S, Feagan BG, et al. Defining disease severity in inflammatory bowel diseases: current and future directions. Clin Gastroenterol Hepatol. 2016;14(3):348–354. e17.
   PubMed Web of Science ®Google Scholar
• Irvine E, Zhou Q, Thompson A. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol. 1996;91(8):1571–1578.
   PubMed Web of Science ®Google Scholar
• Siegel CA, Whitman CB, Spiegel BM, Feagan B, Sands B, Loftus EV, et al. Development of an index to define overall disease severity in IBD. Gut. 2016:gutjnl-2016–312648.
   Web of Science ®Google Scholar
• Huang V, Mishra R, Thanabalan R, Nguyen GC. Patient awareness of extraintestinal manifestations of inflammatory bowel disease. J Crohn's Colitis. 2013;7(8):e318–e24.
   Google Scholar
• Freynhagen R, Baron R, Gockel U, Tölle TR. Pain DETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22(10):1911–1920.
   PubMed Web of Science ®Google Scholar
• Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14(7):798–804.
   PubMed Web of Science ®Google Scholar
• Margolis RB, Chibnall JT, Tait RC. Test-retest reliability of the pain drawing instrument. Pain. 1988;33(1):49–51.
   PubMed Web of Science ®Google Scholar
• Gershon RC, Rothrock N, Hanrahan R, Bass M, Cella D. The use of PROMIS and assessment center to deliver patient-reported outcome measures in clinical research. J Appl Measure. 2010;11(3):304.
   PubMedGoogle Scholar
• Wurpts IC, Geiser C. Is adding more indicators to a latent class analysis beneficial or detrimental? Results of a Monte-Carlo study. Front Psychol. 2014;5:1–15.
   PubMed Web of Science ®Google Scholar
• Finch WH, Bronk KC. Conducting confirmatory latent class analysis using M plus. Struct Equ Model. 2011;18(1):132–151.
   Web of Science ®Google Scholar
• Gudicha DW, Tekle FB, Vermunt JK. Power and sample size computation for Wald tests in latent class models. J Classif. 2016;33(1):30–51.
   Web of Science ®Google Scholar
• Kongsted A, Nielsen AM. Latent Class Analysis in health research. J Physiother. 2017;63(1):55–58.
   PubMedGoogle Scholar
• Hoijtink H. Confirmatory latent class analysis: model selection using Bayes factors and (pseudo) likelihood ratio statistics. Multivariate Behav Res. 2001;36(4):563–588.
   PubMed Web of Science ®Google Scholar
• Laudy O, Boom J, Hoijtink H. Bayesian computational methods for inequality constrained latent class analysis. In: L. Andries van der Ark, Marcel A. Croon, Klaas Sijtsma, (Eds.).New developments in categorical data analysis for the social and behavioral sciences.Psychology PressLocation: New York. 2005. p. 63–82.
   Google Scholar
• Świeboda P, Filip R, Prystupa A, Drozd M. Assessment of pain: types, mechanism and treatment. Pain. 2013;2:7.
   Google Scholar
• Schirbel A, Reichert A, Roll S, Baumgart DC, Büning C, Wittig B, et al. Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol. 2010;16(25):3168–3177.
   PubMed Web of Science ®Google Scholar
• Victor TW, Jensen MP, Gammaitoni AR, Gould EM, White RE, Galer BS. The dimensions of pain quality: factor analysis of the Pain Quality Assessment Scale. Clin J pain. 2008;24(6):550–555.
   PubMed Web of Science ®Google Scholar
• Nijs J, Torres-Cueco R, van Wilgen P, Lluch Girbés E, Struyf F, Roussel N, et al. Applying modern pain neuroscience in clinical practice: criteria for the classification of central sensitization pain. Pain Phys. 2014;17(5):447–457.
   PubMed Web of Science ®Google Scholar
• Nezami BG, Srinivasan S. Enteric nervous system in the small intestine: pathophysiology and clinical implications. Curr Gastroenterol Rep. 2010;12(5):358–365.
   PubMedGoogle Scholar
• Sharkey KA, Kroese A. Consequences of intestinal inflammation on the enteric nervous system: neuronal activation induced by inflammatory mediators. Anat Rec. 2001;262(1):79–90.
   PubMedGoogle Scholar
• White FA, Jung H, Miller RJ. Chemokines and the pathophysiology of neuropathic pain. Proc Natl Acad Sci USA. 2007;104(51):20151–20158.
   PubMed Web of Science ®Google Scholar
• Smart KM, Blake C, Staines A, Thacker M, Doody C. Mechanisms-based classifications of musculoskeletal pain: part 1 of 3: symptoms and signs of central sensitisation in patients with low back (±leg) pain. Manu Ther. 2012;17(4):20144–20151.
   Google Scholar